Cancer Antigen 125 (eCLIA) (UDI 06975984063423)
Manufactured by Shenzhen Lifotronic Technology Co., Ltd.
Device Regulatory Overview
The Cancer Antigen 125 (eCLIA) (Model/Catalog Number: 0320500904) is a medical device manufactured by Shenzhen Lifotronic Technology Co., Ltd.. This product is indexed under FDA Product Code / Category Classification W0102030106 within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- 0320500904
- Product Code / EMDN
- W0102030106
- Device Name
- Cancer Antigen 125 (eCLIA)
- Database Sync Date
- 2026-08-09 16:30:29
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of Cancer Antigen 125 (eCLIA)?
The registered manufacturer of record for Cancer Antigen 125 (eCLIA) is Shenzhen Lifotronic Technology Co., Ltd..
What is the Primary UDI-DI identifier for Cancer Antigen 125 (eCLIA)?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 06975984063423.
What classification code is assigned to this device?
This device is registered under product classification code W0102030106.
Similar Classification Devices (W0102030106)
Other Devices by Shenzhen Lifotronic Technology Co., Ltd.
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint